Selected research
Industry Research
Rhizoma Gastrodiae Tablets Industry Research Report 2026
Market perspective
The global Rhizoma Gastrodiae Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Rhizoma Gastrodiae Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Rhizoma Gastrodiae Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Rhizoma Gastrodiae Tablets include Zhaotong Huacheng Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Tsumura & Co., Lanzhou Foci Pharmaceutical, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Guangdong Luofushan National Pharmaceutical and Tongrentang Chinese Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Rhizoma Gastrodiae Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rhizoma Gastrodiae Tablets Market by Company
Zhaotong Huacheng Pharmaceutical
Taiji Group Sichuan Mianyang Pharmaceutical
Shaanxi Tianyang Pharmaceutical
Tsumura & Co.
Lanzhou Foci Pharmaceutical
Guizhou Bailing
Guangxi Chanfang Pharmaceutical
Guangdong Luofushan National Pharmaceutical
Tongrentang Chinese Medicine
Rhizoma Gastrodiae Tablets Segment by Type
Gastrodia elata f.glauca
G.elata.BI.f elata
Other
Rhizoma Gastrodiae Tablets Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Rhizoma Gastrodiae Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rhizoma Gastrodiae Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rhizoma Gastrodiae Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rhizoma Gastrodiae Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rhizoma Gastrodiae Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rhizoma Gastrodiae Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gastrodia elata f.glauca
- G.elata.BI.f elata
- Other
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Zhaotong Huacheng Pharmaceutical
- Taiji Group Sichuan Mianyang Pharmaceutical
- Shaanxi Tianyang Pharmaceutical
- Tsumura & Co.
- Lanzhou Foci Pharmaceutical
- Guizhou Bailing
- Guangxi Chanfang Pharmaceutical
- Guangdong Luofushan National Pharmaceutical
- Tongrentang Chinese Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rhizoma Gastrodiae Tablets Market Size (2021-2032)
- 2.2.2 Global Rhizoma Gastrodiae Tablets Sales (2021-2032)
- 2.2.3 Global Rhizoma Gastrodiae Tablets Market Average Price (2021-2032)
- 2.3 Rhizoma Gastrodiae Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gastrodia elata f.glauca
- 2.3.3 G.elata.BI.f elata
- 2.3.4 Other
- 2.4 Rhizoma Gastrodiae Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rhizoma Gastrodiae Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rhizoma Gastrodiae Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Rhizoma Gastrodiae Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Rhizoma Gastrodiae Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Rhizoma Gastrodiae Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rhizoma Gastrodiae Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rhizoma Gastrodiae Tablets, Product Type & Application
- 3.8 Global Manufacturers of Rhizoma Gastrodiae Tablets, Established Date
- 3.9 Global Rhizoma Gastrodiae Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhaotong Huacheng Pharmaceutical
- 4.1.1 Zhaotong Huacheng Pharmaceutical Company Information
- 4.1.2 Zhaotong Huacheng Pharmaceutical Business Overview
- 4.1.3 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.1.5 Zhaotong Huacheng Pharmaceutical Recent Developments
- 4.2 Taiji Group Sichuan Mianyang Pharmaceutical
- 4.2.1 Taiji Group Sichuan Mianyang Pharmaceutical Company Information
- 4.2.2 Taiji Group Sichuan Mianyang Pharmaceutical Business Overview
- 4.2.3 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.2.5 Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments
- 4.3 Shaanxi Tianyang Pharmaceutical
- 4.3.1 Shaanxi Tianyang Pharmaceutical Company Information
- 4.3.2 Shaanxi Tianyang Pharmaceutical Business Overview
- 4.3.3 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.3.5 Shaanxi Tianyang Pharmaceutical Recent Developments
- 4.4 Tsumura & Co.
- 4.4.1 Tsumura & Co. Company Information
- 4.4.2 Tsumura & Co. Business Overview
- 4.4.3 Tsumura & Co. Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio
- 4.4.5 Tsumura & Co. Recent Developments
- 4.5 Lanzhou Foci Pharmaceutical
- 4.5.1 Lanzhou Foci Pharmaceutical Company Information
- 4.5.2 Lanzhou Foci Pharmaceutical Business Overview
- 4.5.3 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.5.5 Lanzhou Foci Pharmaceutical Recent Developments
- 4.6 Guizhou Bailing
- 4.6.1 Guizhou Bailing Company Information
- 4.6.2 Guizhou Bailing Business Overview
- 4.6.3 Guizhou Bailing Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio
- 4.6.5 Guizhou Bailing Recent Developments
- 4.7 Guangxi Chanfang Pharmaceutical
- 4.7.1 Guangxi Chanfang Pharmaceutical Company Information
- 4.7.2 Guangxi Chanfang Pharmaceutical Business Overview
- 4.7.3 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.7.5 Guangxi Chanfang Pharmaceutical Recent Developments
- 4.8 Guangdong Luofushan National Pharmaceutical
- 4.8.1 Guangdong Luofushan National Pharmaceutical Company Information
- 4.8.2 Guangdong Luofushan National Pharmaceutical Business Overview
- 4.8.3 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
- 4.8.5 Guangdong Luofushan National Pharmaceutical Recent Developments
- 4.9 Tongrentang Chinese Medicine
- 4.9.1 Tongrentang Chinese Medicine Company Information
- 4.9.2 Tongrentang Chinese Medicine Business Overview
- 4.9.3 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio
- 4.9.5 Tongrentang Chinese Medicine Recent Developments
5 Global Rhizoma Gastrodiae Tablets Market Scenario by Region
- 5.1 Global Rhizoma Gastrodiae Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021-2032
- 5.2.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021-2026
- 5.2.2 Global Rhizoma Gastrodiae Tablets Sales by Region: 2027-2032
- 5.3 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2027-2032
- 5.4 North America Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
- 5.4.1 North America Rhizoma Gastrodiae Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
- 5.4.3 North America Rhizoma Gastrodiae Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
- 5.5.1 Europe Rhizoma Gastrodiae Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Rhizoma Gastrodiae Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rhizoma Gastrodiae Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rhizoma Gastrodiae Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
- 5.7.1 South America Rhizoma Gastrodiae Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
- 5.7.3 South America Rhizoma Gastrodiae Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rhizoma Gastrodiae Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rhizoma Gastrodiae Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
- 6.1.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
- 7.1.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rhizoma Gastrodiae Tablets Value Chain Analysis
- 8.1.1 Rhizoma Gastrodiae Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rhizoma Gastrodiae Tablets Production Mode & Process
- 8.2 Rhizoma Gastrodiae Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rhizoma Gastrodiae Tablets Distributors
- 8.2.3 Rhizoma Gastrodiae Tablets Customers
9 Global Rhizoma Gastrodiae Tablets Analyzing Market Dynamics
- 9.1 Rhizoma Gastrodiae Tablets Industry Trends
- 9.2 Rhizoma Gastrodiae Tablets Industry Drivers
- 9.3 Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges
- 9.4 Rhizoma Gastrodiae Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst